Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Antiviral symbols : PFE save search
Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published: 2023-01-16 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.2%
H: 0.0%
C: 0.0%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -2.74%
H: 0.43%
C: -0.99%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.33%
H: 0.33%
C: -0.94%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.83%
H: 0.52%
C: -1.09%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.01%
H: 0.69%
C: -0.1%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.1%
H: 0.22%
C: 0.02%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: -0.26%
H: 0.37%
C: -0.74%
COCP | $1.43 -1.39% 5.1K
|
Health Technology
|
| O: 0.47%
H: 11.16%
C: 7.91%
hepatitis global antiviral hiv therapeutics growth market
Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment
Published: 2021-12-22 (Crawled : 20:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.51%
H: 2.25%
C: 0.51%
covid-19 treatment fda covid authorization antiviral merge emergency use authorization
Pfizer to Provide the United Kingdom an Additional 2.5 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19
Published: 2021-12-22 (Crawled : 11:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.51%
H: 2.25%
C: 0.51%
covid-19 treatment covid antiviral
Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death
Published: 2021-12-14 (Crawled : 12:30) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 1.99%
H: 0.0%
C: 0.0%
covid-19 treatment phase 2 risk phase 2/3 covid antiviral results
Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Discuss Pfizer-BioNTech COVID-19 Vaccine and Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate
Published: 2021-12-07 (Crawled : 19:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
treatment covid antiviral vaccine covid-19
Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19
Published: 2021-11-18 (Crawled : 13:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 2.34%
H: 1.19%
C: 0.61%
covid treatment antiviral
Pfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income Countries
Published: 2021-11-16 (Crawled : 12:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
covid treatment antiviral patent license
Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study
Published: 2021-11-05 (Crawled : 11:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 8.64%
H: 0.0%
C: 0.0%
covid treatment phase 2 risk phase 2/3 antiviral
Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults
Published: 2021-09-27 (Crawled : 11:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.34%
H: 0.48%
C: -0.8%
covid phase 2 phase 2/3 antiviral
Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2
Published: 2021-03-23 (Crawled : 18:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.5%
H: 0.31%
C: -1.28%
phase 1 antiviral phase 3 phase 2 sars-cov-2
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.